Alnajashi, H. (2025) “Rituximab as an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review”, Journal of Contemporary Medical Sciences, 11(3). doi: 10.22317/jcms.v11i3.1892.